- Filed
- Jun 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Jun 16, 2025 | 54.25M sh |
| Shares Diluted | FY 2025 · Mar 31, 2025 | 37.01M sh |
| Shares Diluted | FY 2025 · Mar 31, 2024 | 22.38M sh |
| Capex | FY 2025 · Mar 31, 2025 | $2.49M |
| Capex | FY 2025 · Mar 31, 2024 | $1.7M |
| Operating Cash Flow | FY 2025 · Mar 31, 2025 | −$15.72M |
| Operating Cash Flow | FY 2025 · Mar 31, 2024 | −$13.95M |
| Cash And Equivalents | FY 2025 · Mar 31, 2025 | $13.1M |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $9.23M |
| Stockholders Equity | FY 2025 · Mar 31, 2025 | $17.08M |
| Stockholders Equity | FY 2025 · Mar 31, 2024 | $11.54M |
| Stockholders Equity restated | FY 2025 · Mar 31, 2023 | $5.08M |
| Current Liabilities | FY 2025 · Mar 31, 2025 | $1.27M |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $1.46M |
| Total Liabilities | FY 2025 · Mar 31, 2025 | $1.66M |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $2.27M |
| Current Assets | FY 2025 · Mar 31, 2025 | $13.52M |
| Current Assets | FY 2025 · Mar 31, 2024 | $9.7M |
| Total Assets | FY 2025 · Mar 31, 2025 | $18.74M |
| Total Assets | FY 2025 · Mar 31, 2024 | $13.81M |
| Eps Diluted | FY 2025 · Mar 31, 2025 | −$0.51 |
| Eps Diluted | FY 2025 · Mar 31, 2024 | −$0.78 |
| Eps Basic | FY 2025 · Mar 31, 2025 | −$0.51 |
| Eps Basic | FY 2025 · Mar 31, 2024 | −$0.78 |
| Sga Expense | FY 2025 · Mar 31, 2025 | $4.35M |
| Sga Expense | FY 2025 · Mar 31, 2024 | $4.65M |
| Rd Expense | FY 2025 · Mar 31, 2025 | $14.7M |
| Rd Expense | FY 2025 · Mar 31, 2024 | $12.88M |
| Net Income | FY 2025 · Mar 31, 2025 | −$18.82M |
| Net Income | FY 2025 · Mar 31, 2024 | −$17.47M |
| Operating Income | FY 2025 · Mar 31, 2025 | −$19.05M |
| Operating Income | FY 2025 · Mar 31, 2024 | −$17.53M |